default author photo

Minghao Dang

University of Texas at Houston - Department of Genomic Medicine

SCHOLARLY PAPERS

3

DOWNLOADS

150

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Single Cell Clonotypic and Transcriptional Evolution of Multiple Myeloma Precursor Disease

Number of pages: 68 Posted: 09 Nov 2022
University of Texas at Houston - Department of Genomic Medicine, University of Texas at Houston - Department of Genomic Medicine, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - Department of Genomic Medicine, University of Texas at Houston - Department of Genomic Medicine, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - Department of Hematopathology, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - Department of Genomic Medicine, University of Texas at Houston - Department of Genomic Medicine, University of Texas at Houston - Department of Genomic Medicine, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Southern California - Keck School of Medicine, University of Southern California - Keck School of Medicine, University of Southern California - Keck School of Medicine, University of Southern California, University of Southern California, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - Department of Genomic Medicine and University of Texas at Houston - Department of Lymphoma and Myeloma
Downloads 60 (961,006)

Abstract:

Loading...

single-cell RNA sequencing (scRNAseq), multiple myeloma (MM), monoclonal gammopathy of undetermined significance (MGUS), smoldering multiple myeloma (SMM), single-cell B cell receptor sequencing (scBCR-seq), plasma cells (PCs), intra-tumoral heterogeneity (ITH), tumor microenvironment (TME), hyperdiploid (HY), non-hyperdiploid (non-HY)

2.

Phase II Trial of Pembrolizumab in Combination with Chemotherapy for Frontline Treatment of Advanced Epithelial Ovarian Cancer

Number of pages: 44 Posted: 28 Mar 2024
University of Texas at Houston - Department of Gynecologic Oncology and Reproductive Medicine, University of Texas at Houston - Department of Genomic Medicine, University of Texas at Houston - Department of Gynecologic Oncology and Reproductive Medicine, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Gynecologic Oncology and Reproductive Medicine, University of Texas at Houston - Department of Gynecologic Oncology and Reproductive Medicine, University of Texas at Houston - Department of Gynecologic Oncology and Reproductive Medicine, University of Texas at Houston - Department of Gynecologic Oncology and Reproductive Medicine, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Genomic Medicine, University of Texas at Houston - Department of Gynecologic Oncology and Reproductive Medicine, University of Texas at Houston - Department of Gynecologic Oncology and Reproductive Medicine, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Translational Molecular Pathology, University of Texas at Houston - Department of Translational Molecular Pathology, University of Texas at Houston - Department of Translational Molecular Pathology, University of Texas at Houston - Department of Translational Molecular Pathology, University of Texas at Houston - Department of Gynecologic Oncology and Reproductive Medicine, Texas Oncology, University of Texas at Houston - Department of Gynecologic Oncology and Reproductive Medicine, Texas Oncology, University of Texas at Houston - Department of Genomic Medicine and University of Texas at Houston - Department of Gynecologic Oncology and Reproductive Medicine
Downloads 49 (1,074,648)

Abstract:

Loading...

pembrolizumab, combination chemotherapy, ovarian cancer, immunotherapy, tumor immune microenvironment, translational, clinical trial, feasibility

3.

MCT4-Dependent Lactate Secretion Suppresses Antitumor Immunity in LKB1-Deficient NSCLC

Number of pages: 50 Posted: 23 Sep 2022
University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Genomic Medicine, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Bioinformatics and Computational Biology, University of Texas at Houston - Department of Bioinformatics and Computational Biology, University of Texas at Houston - Department of Translational Molecular Pathology, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Translational Molecular Pathology, Memorial Sloan Kettering Cancer Center - Ludwig Collaborative and Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center - Ludwig Collaborative and Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center - Ludwig Collaborative and Swim Across America Laboratory, New York University (NYU) - Thoracic Oncology Program, University of Texas at Dallas - Children’s Medical Center Research Institute, University of Texas at Dallas - Hamon Center for Therapeutic Oncology Research, University of Texas at Houston - Department of Genomic Medicine, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology and University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology
Downloads 41 (1,170,409)

Abstract:

Loading...

LKB1, lung adenocarcinoma, PD-1, immunotherapy resistance, lactate, MCT4, T cell activation, macrophage polarization, metabolism